BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36359316)

  • 1. Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture.
    Marín-Payá JC; Clara-Trujillo S; Cordón L; Gallego Ferrer G; Sempere A; Gómez Ribelles JL
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic 3D Environment Based on Microgels as a Model for the Generation of Drug Resistance in Multiple Myeloma.
    Marín-Payá JC; Díaz-Benito B; Martins LA; Trujillo SC; Cordón L; Lanceros-Méndez S; Gallego Ferrer G; Sempere A; Gómez Ribelles JL
    Materials (Basel); 2021 Nov; 14(23):. PubMed ID: 34885273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel microgel culture system as semi-solid three-dimensional in vitro model for the study of multiple myeloma proliferation and drug resistance.
    Clara-Trujillo S; Tolosa L; Cordón L; Sempere A; Gallego Ferrer G; Gómez Ribelles JL
    Biomater Adv; 2022 Apr; 135():212749. PubMed ID: 35929221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells.
    Kikuchi J; Koyama D; Mukai HY; Furukawa Y
    Int J Hematol; 2014 Jun; 99(6):726-36. PubMed ID: 24706190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib.
    Francisco V; Ruiz-Fernández C; González-Rodríguez M; Cordero-Barreal A; Pino J; Viñuela JE; Lago F; Conde J; Gómez R; Carvalho GR; Costa Pereira TM; Campos-Toimil M; Gualillo O
    J Ethnopharmacol; 2021 May; 272():113932. PubMed ID: 33609728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.
    Yanamandra N; Colaco NM; Parquet NA; Buzzeo RW; Boulware D; Wright G; Perez LE; Dalton WS; Beaupre DM
    Clin Cancer Res; 2006 Jan; 12(2):591-9. PubMed ID: 16428505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of normal human bone marrow fibroblastoid stromal cell line on the proliferation of multiple myeloma cell line RPMI8226].
    Jin XQ; Bai QX; Liang R; Chen XQ; Huang GS; Dong BX; Zhang WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):475-9. PubMed ID: 15363135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.
    Belloni D; Heltai S; Ponzoni M; Villa A; Vergani B; Pecciarini L; Marcatti M; Girlanda S; Tonon G; Ciceri F; Caligaris-Cappio F; Ferrarini M; Ferrero E
    Haematologica; 2018 Apr; 103(4):707-716. PubMed ID: 29326121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib
    Li G; Zheng YH; Xu L; Feng J; Tang HL; Luo C; Song YP; Chen XQ
    Ther Adv Hematol; 2020; 11():2040620720932686. PubMed ID: 32551032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
    Ding T; Hao J
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib inhibits the survival and proliferation of bone marrow stromal cells.
    Kim HY; Moon JY; Ryu H; Choi YS; Song IC; Lee HJ; Yun HJ; Kim S; Jo DY
    Blood Res; 2015 Jun; 50(2):87-96. PubMed ID: 26157778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment factors do not afford myeloma cell lines protection from simvastatin.
    Osadchy A; Drucker L; Radnay J; Shapira H; Lishner M
    Eur J Haematol; 2004 Sep; 73(3):183-90. PubMed ID: 15287916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma.
    Vincent T; Molina L; Espert L; Mechti N
    Br J Haematol; 2003 Apr; 121(2):259-69. PubMed ID: 12694247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.
    Shen Y; Sun Y; Zhang L; Liu H
    Tumour Biol; 2017 Jun; 39(6):1010428317703941. PubMed ID: 28653881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteasome inhibitor induces apoptosis and influences the expression of Notch1 and NF-kappaB in multiple myeloma RPMI8226 cells].
    Wang H; Liu X; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):531-7. PubMed ID: 18549623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.
    Li X; Yang Y; Yi X
    Technol Cancer Res Treat; 2020; 19():1533033820936770. PubMed ID: 32799769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma.
    Peng J; Thakur A; Zhang S; Dong Y; Wang X; Yuan R; Zhang K; Guo X
    Tumour Biol; 2015 Nov; 36(11):8545-52. PubMed ID: 26032093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
    Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
    Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid metabolism reduces human myeloma cells proliferation.
    Tirado-Vélez JM; Joumady I; Sáez-Benito A; Cózar-Castellano I; Perdomo G
    PLoS One; 2012; 7(9):e46484. PubMed ID: 23029529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.